Yahoo
NasdaqCM - Delayed Quote USD

Intelligent Bio Solutions Inc. (INBS)

1.7600 -0.0700 (-3.83%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for INBS
  • Previous Close 1.8300
  • Open 1.8100
  • Bid 1.2100 x 200
  • Ask 2.1200 x 200
  • Day's Range 1.6900 - 1.8200
  • 52 Week Range 1.3500 - 24.9000
  • Volume 17,974
  • Avg. Volume 144,056
  • Market Cap (intraday) 5.838M
  • Beta (5Y Monthly) 4.30
  • PE Ratio (TTM) --
  • EPS (TTM) -8.4400
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 12.00
  • Zacks Rating Neutral

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

ibs.inc

59

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

INBS
81.53%
S&P 500 (^GSPC)
10.73%

1-Year Return

INBS
82.91%
S&P 500 (^GSPC)
11.11%

3-Year Return

INBS
93.62%
S&P 500 (^GSPC)
81.91%

5-Year Return

INBS
99.96%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY26
Revenue 1.15M
Earnings -3.91M
Profit Margin -341.04%

Q3

FY24

Q4

FY24

Q3

FY26

Q4

FY26

-3M
-2M
-1M
0
1M
-300.0%
-200.0%
-100.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

12.00
12.00 Average
1.7600 Current
12.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -294.91%

  • Return on Assets (ttm)

    -76.20%

  • Return on Equity (ttm)

    -307.69%

  • Revenue (ttm)

    4.22M

  • Net Income Avi to Common (ttm)

    -12.43M

  • Diluted EPS (ttm)

    -8.4400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.14M

  • Total Debt/Equity (mrq)

    34.38%

  • Levered Free Cash Flow (ttm)

    -6.72M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: